反応 #40649

ord-4ff04c5e94c1429fb6e2c8b432ea5d8a

反応方程式

NC(Cc1ccc(F)cc1)C1(O)CCN(C(=O)OCc2ccccc2)CC1
aminoalcohol
NC(Cc1ccc(F)cc1)C1(O)CCN(C(=O)OCc2ccccc2)CC1
4-[1-Amino-2-(4-fluorophenyl)-ethyl]-4-hydroxypiperidine-1-carboxylic acid benzyl ester
[I-].[Na+]
NaI
O=C(Cl)CCl
chloroacetylchloride
[I-]
iodide
CC(C)(C)[O-]
tert-butoxide
O=C1COC2(CCN(C(=O)OCc3ccccc3)CC2)C(Cc2ccc(F)cc2)N1
title compound
収率 19.0%
O=C1COC2(CCN(C(=O)OCc3ccccc3)CC2)C(Cc2ccc(F)cc2)N1
5-(4-Fluorobenzyl)-3-oxo-1-oxa-4,9-diaza-spiro[5.5]undecane-9-carboxylic acid benzyl ester
収率 19.0%

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他Purification of the crude product by silica gel column chromatography
  2. 2
    洗浄eluting with a stepwise gradient of 0-100% ethyl acetate in n-heptane

実験手順

The title compound was prepared from aminoalcohol 103NLS28 (303 mg, 0.81 mmol) according to literature procedures (Clark et al., J. Med. Chem. 26:855-861 (1983)), by acylation of the amino function with chloroacetylchloride, followed by halogen exchange with NaI and ring closure of the iodide derivative in presence of tert-butoxide. Purification of the crude product by silica gel column chromatography, eluting with a stepwise gradient of 0-100% ethyl acetate in n-heptane, afforded the title compound (64 mg, 19% overall yield) as a colourless solid.

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07727999B2uspto-grants-2010_06